MedPath

Effects of Septorhinoplasty on Allergic Rhinitis

Not Applicable
Completed
Conditions
Allergic Rhinitis
Interventions
Procedure: Septorhinoplasty
Registration Number
NCT04871256
Lead Sponsor
Mario Pérez Sayáns
Brief Summary

Allergic rhinitis (AR) is a chronic inflammatory disease that affects almost 30% of adult population. Some patients associate septal deviation, main cause of chronic nasal obstruction, and AR. Current literature about AR treatment with septoplasty (STP) is still contradictory, because is thought that patients with AR are not able to appreciate improvement after surgery.

Patients diagnosed with allergic rinitis and septal deviation were evaluated to determined life quality and airflow obstruction evolution after STP.

Detailed Description

This is a prospective quasi experimental study. After being informed about the study, patients that signed written informed consent were included in the study. In week 0 before surgery, all measurements and questionnaires were performed. 1 month after surgery, measurements were repeated.

After screening, patient´s obstruction was evaluated by anterior rhinomanometry (RNMa), and quality of life scored through ESPRINT scale. ESPRINT is a validated Spanish questionnaire about daily life activity, sleep, psycology and perception of affection by allergic rhinitis. Symtoms were evaluated with visual analogue scale (VAS) and clinical history. Symptoms like sneezing, itchy nose, ocular symptoms and/or nasal obstruction. Also medication (intranasal corticosteroid, antileucotrienos, antihistamines eye drops , antishistamines) frequency use was registered.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Clinical diagnosis of Allergic Rhinitis
  • Diagnosis of nasal obstruction with septal deviation
Exclusion Criteria
  • Previous nasal surgery
  • Smokers
  • Chronic obstructive pulmonary disease
  • Psychiatric disorders
  • Malignant tumors
  • Severe hepatopathy
  • Obstructive sleep apnea

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
InverSeptorhinoplastyIntervention: after screening, patient´s obstruction will be evaluated by anterior rhinomanometry (RNMa), and quality of life wil be scored through ESPRINT scale. ESPRINT is a validated Spanish questionnaire about daily life activity, sleep, psychology and perception of affection by allergic rhinitis. Symptoms will be evaluated with visual analogue scale (VAS) and clinical history. Symptoms like sneezing, itchy nose, ocular symptoms and/or nasal obstruction. Also medication (intranasal corticosteroid, antileukotrienes, antihistamine eye drops, antihistamine) frequency use will be registered
Primary Outcome Measures
NameTimeMethod
Changes from baseline of Airflow rateChange from baseline airflow rate (Before treatment) at 1 month after surgery

Rhinomanometre will be used to determine airflow rate changes before surgery (septoplasty) and after it. Rhinomanometre will determine airflow rate in cm3/s and also use a quality scale as normal, mild, severe and very severe

Secondary Outcome Measures
NameTimeMethod
Changes from baseline of symptomsChanges from baseline (Before treatment) at 1 month after surgery

VAS score. VAS: visual analogue scale. Patients determine their symptoms with a visual scale that range from 0-10.

Changes from baseline in quality of lifeChanges from baseline (Before treatment) at 1 month after surgery

ESPRINT questionnaire. This is a validated spanish questionnaire about daily life impairments with 28 items.

Trial Locations

Locations (1)

Mario Pérez Sayáns

🇪🇸

Santiago De Compostela, A Coruña, Spain

© Copyright 2025. All Rights Reserved by MedPath